1. Home
  2. TKO vs NBIX Comparison

TKO vs NBIX Comparison

Compare TKO & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TKO Group Holdings Inc.

TKO

TKO Group Holdings Inc.

HOLD

Current Price

$186.62

Market Cap

15.1B

Sector

N/A

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$131.62

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TKO
NBIX
Founded
1980
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.1B
13.2B
IPO Year
2023
1996

Fundamental Metrics

Financial Performance
Metric
TKO
NBIX
Price
$186.62
$131.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
17
22
Target Price
$224.53
$180.91
AVG Volume (30 Days)
1.1M
1.1M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
1.70%
N/A
EPS Growth
11200.00
41.95
EPS
2.26
4.67
Revenue
$4,735,151,000.00
$161,626,000.00
Revenue This Year
$23.14
$24.73
Revenue Next Year
$1.05
$13.14
P/E Ratio
$82.37
$28.21
Revenue Growth
68.85
977.51
52 Week Low
$152.29
$108.47
52 Week High
$226.94
$160.18

Technical Indicators

Market Signals
Indicator
TKO
NBIX
Relative Strength Index (RSI) 42.02 53.32
Support Level $180.29 $124.62
Resistance Level $192.80 $135.30
Average True Range (ATR) 5.64 3.41
MACD 0.16 0.17
Stochastic Oscillator 30.65 70.73

Price Performance

Historical Comparison
TKO
NBIX

About TKO TKO Group Holdings Inc.

TKO Group Holdings Inc is a sports and sports entertainment company that operates combat sports and sports entertainment companies. It owns and manages valuable sports and entertainment intellectual property. The company distributes content and monetizes its intellectual property through four activities: Media rights, production, and content, Live events and hospitality, Partnerships and marketing and Consumer products licensing, The company has two reportable segments, UFC and WWE. The company generates majority of revenue from the UFC segment. The UFC segment revenue consists of media rights fees associated with the distribution of its programming content, ticket sales, and site fees associated with the business's international live events.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: